Acarix AB

OSTO:ACARIX (Sweden)  
kr 0.28 (-2.48%) Dec 23
At Loss
P/B:
4.92
Market Cap:
kr 292.53M ($ 26.39M)
Enterprise V:
kr 248.35M ($ 22.41M)
Volume:
1.56M
Avg Vol (2M):
3.58M
Trade In:
Volume:
1.56M
At Loss
Avg Vol (2M):
3.58M

Business Description

Description
Acarix AB is a Swedish medical technology company that develops innovative solutions for rapid AI-based exclusion of coronary artery disease (CAD). The CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics. The CADScor System uses advanced acoustics and AI technology to non-invasively rule out CAD in less than 10 minutes, with at least 96 percent certainty.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.87
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.86
Distress
Grey
Safe
Beneish M-Score -2.76
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 52.17
9-Day RSI 47.53
14-Day RSI 45.13
6-1 Month Momentum % -6.53
12-1 Month Momentum % 65.79

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.62
Quick Ratio 6
Cash Ratio 4.66
Days Inventory 4379.6
Days Sales Outstanding 157.44
Days Payable 2251.74

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -58.7
Shareholder Yield % -39.95

Financials (Next Earnings Date:2025-02-13)

OSTO:ACARIX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Acarix AB Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 5.677
EPS (TTM) (kr) -0.09
Beta 0
Volatility % 87.29
14-Day RSI 45.13
14-Day ATR (kr) 0.024158
20-Day SMA (kr) 0.279525
12-1 Month Momentum % 65.79
52-Week Range (kr) 0.1688 - 0.599
Shares Outstanding (Mil) 1,063.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Acarix AB Filings

Filing Date Document Date Form
No Filing Data

Acarix AB Stock Events

Financials Calendars
Event Date Price(kr)
No Event Data

Acarix AB Frequently Asked Questions

What is Acarix AB(OSTO:ACARIX)'s stock price today?
The current price of OSTO:ACARIX is kr0.28. The 52 week high of OSTO:ACARIX is kr0.60 and 52 week low is kr0.17.
When is next earnings date of Acarix AB(OSTO:ACARIX)?
The next earnings date of Acarix AB(OSTO:ACARIX) is 2025-02-13.
Does Acarix AB(OSTO:ACARIX) pay dividends? If so, how much?
Acarix AB(OSTO:ACARIX) does not pay dividend.

Press Release

Subject Date
No Press Release